AIM
INDV icon

ARGA Investment Management’s Indivior Pharmaceuticals INDV Stock Holding History

ARGA Investment Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,169
Closed -$473K – 122
2025
Q4 		$473K Hold
13,169
– – 0.01% 90
2025
Q3 		$318K Buy
+13,169
New +$276K 0.01% 100

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

ARGA Investment Management's INDV Position: Q1 2026 in Review

ARGA Investment Management sold out of Indivior Pharmaceuticals (INDV) in Q1 2026, closing a stake of 13,169 shares — an estimated $473K sold.

ARGA Investment Management first reported a position in INDV in Q3 2025 and held it in 2 quarters. The position peaked at $473K in Q4 2025. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • ARGA Investment Management reported no remaining Indivior Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • ARGA Investment Management sold 13,169 Indivior Pharmaceuticals shares in Q1 2026, an estimated $473K.
  • ARGA Investment Management first reported a position in Indivior Pharmaceuticals in Q3 2025 and held it in 2 quarters.
  • ARGA Investment Management's Indivior Pharmaceuticals position peaked at $473K in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on ARGA Investment Management's 13F filing for Q1 2026, filed 30 Apr 2026.